Company Filing History:
Years Active: 2014
Title: Yan Yang - Innovator in Pharmaceutical Formulations
Introduction
Yan Yang is a notable inventor based in Roslyn Heights, NY (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of immediate release dosage forms.
Latest Patents
Yan Yang holds a patent for "Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane." This invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating. The active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibiting an average T within the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. This formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of T.
Career Highlights
Throughout her career, Yan Yang has worked with prominent companies in the pharmaceutical industry. She has been associated with Forest Laboratories Holdings Limited and Merz Pharma GmbH & Co Kgaa, where she has contributed her expertise in drug formulation and development.
Collaborations
Yan Yang has collaborated with several professionals in her field, including Rajiv Janjikhel and Niranjan Rao. These collaborations have further enhanced her work and contributions to pharmaceutical innovations.
Conclusion
Yan Yang is a distinguished inventor whose work in immediate release formulations has the potential to impact the pharmaceutical industry significantly. Her innovative approach and collaborations with industry professionals highlight her commitment to advancing drug delivery systems.